iBio (IBIO) Amortization of Deferred Charges (2021 - 2026)

iBio (IBIO) has 6 years of Amortization of Deferred Charges data on file, last reported at $98000.0 in Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 10.11% year-over-year to $98000.0 in Q1 2026; TTM through Mar 2026 was $377000.0, a 17.08% increase from a year earlier, with the FY2025 full-year figure at $351000.0, up 9.35% from the prior year.
• Amortization of Deferred Charges for Q1 2026 stood at $98000.0, up from $95000.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for IBIO reached as high as $143000.0 in Q3 2022 and fell as low as $58000.0 in Q4 2022.
• Historically, Amortization of Deferred Charges has averaged $93176.5 across 5 years, with a median of $89000.0 in 2023.
• Across the five-year window, Amortization of Deferred Charges tumbled 76.42% in 2022 and soared 46.77% in 2025, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $58000.0 in 2022, then jumped by 41.38% to $82000.0 in 2023, then grew by 4.88% to $86000.0 in 2024, then grew by 10.47% to $95000.0 in 2025, then increased by 3.16% to $98000.0 in 2026.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $98000.0 in Q1 2026, $95000.0 in Q4 2025, and $93000.0 in Q3 2025.